Feedback
OncLive®
AJMC®
Pharmacy Times®
Specialty Pharmacy Times
Intelligent Virtual Agents in Health Care
Thomas Morrow, MD
Discover a revolutionary, efficient, and effective way to amplify the "high touch" of specialty pharmacy with the use of technology as patients embrace new tools to monitor their health.
FDA Responds to SPAARx, Agrees to Delete “Specialty Pharmacy” from Compounding Legislation
Randi Hernandez, MS, Associate Editor/Online
The FDA indicated in a letter to SPAARx that future compounding legislation will omit the term “specialty pharmacy.”
Florida Blocks Biosimilar Limitations
Eileen Oldfield, Associate Editor, Pharmacy Times
A bill passed by the Florida legislature would allow pharmacists to substitute biosimilars for brand-named biologics provided that a number of criteria are met.
Pricing and Contracting Strategies Factor into Payer Determination of “Best Products” in Specialty
Randi Hernandez, MS, Associate Editor/Online
The value of a specialty therapy lies not only in its clinical safety and efficacy, but also in how its price compares with other therapies in its class, found a new report.
Eisai, Inc's Fycompa
Monica Holmberg, PharmD, BCPS
The FDA approved Fycompa (perampanel) tablets as an adjunctive therapy for adult patients with epilepsy for the treatment of partial-onset seizures with or without secondarily generalized seizures.
Specialty Pharmacist of the Year Awarded to a pharmacist who excels in providing specialty pharmacy services in a variety of settings, including health systems, community pharmacy, skilled nursing facilities, assisted living communities, continuing care retirement centers, and long-term care organizations.

Sponsored By:

Featured Video
The Financial Footprint of a Specialty Patient
Einodshofer explains how the costs associated with one specialty patient's treatment can have the same financial footprint as an entire population of patients. Video from PBMI's Drug Benefit Conference 2013.
Current Issue
Volume: 4
Number: 2
Conference Calendar
â—„        May 2013        â–ş
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
262728293031
Featured Company Profile
Pluristem: Pioneering Off-the-Shelf Stem Cell Therapies
Beyond providing a potential treatment for a range of serious illnesses, Pluristem has developed a technology that may have unlocked the future for stem cell manufacturing in the pharmaceutical industry.
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2012
Intellisphere, LLC. All Rights Reserved.